Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The polysaccharide capsule of *Neisseria meningitidis* serogroup Y is a major virulence factor composed of repeating units of sialic acid linked to glucose or galactose. Encoded by genes within the *cps* locus, this capsule enables the bacterium to evade host immune responses, specifically preventing phagocytosis and complement-mediated killing. It is a key target for vaccines designed to prevent invasive meningococcal disease. Rising incidence rates of serogroup Y, especially certain hypervirulent strains, underscore its clinical importance.
Vaccine-induced antibody production against the capsule, leading to opsonization and complement-mediated killing of bacteria
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria meningitidis Polysaccharide Capsule (Serogroup Y) (Serogroup Y Capsule).